Observational studyPloS one2023

Real-life comparison of efficacy and safety profiles of two prolonged-release tacrolimus formulations in de novo kidney transplant recipients: 24 months of follow-up.

Paulina Czarnecka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.